Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

BACKGROUND: Immunohistochemistry (IHC) with mutation-specific antibodies may be an ancillary method of detecting EGFR mutations in lung cancer patients. METHODS: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non-small-cell lung cancer (NSCLC) cell lines and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonetti, Sara, Molina, Miguel Angel, Queralt, Cristina, de Aguirre, Itziar, Mayo, Clara, Bertran-Alamillo, Jordi, Sanchez, José Javier, Gonzalez-Larriba, Jose Luis, Jimenez, Ulpiano, Isla, Dolores, Moran, Teresa, Viteri, Santiago, Camps, Carlos, Garcia-Campelo, Rosario, Massuti, Bartomeu, Benlloch, Susana, y Cajal, Santiago Ramon, Taron, Miquel, Rosell, Rafael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016260/
https://www.ncbi.nlm.nih.gov/pubmed/21167064
http://dx.doi.org/10.1186/1479-5876-8-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016260/
https://www.ncbi.nlm.nih.gov/pubmed/21167064
http://dx.doi.org/10.1186/1479-5876-8-135

Ejemplares similares